Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $66.7 million.

  • Angiodynamics' Goodwill & Intangibles fell 872.38% to $66.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was $66.7 million, marking a year-over-year decrease of 872.38%. This contributed to the annual value of $69.1 million for FY2025, which is 1068.32% down from last year.
  • As of Q4 2025, Angiodynamics' Goodwill & Intangibles stood at $66.7 million, which was down 872.38% from $68.4 million recorded in Q3 2025.
  • Angiodynamics' 5-year Goodwill & Intangibles high stood at $387.3 million for Q1 2021, and its period low was $66.7 million during Q4 2025.
  • In the last 5 years, Angiodynamics' Goodwill & Intangibles had a median value of $268.0 million in 2023 and averaged $230.8 million.
  • In the last 5 years, Angiodynamics' Goodwill & Intangibles plummeted by 455.18% in 2022 and then plummeted by 7557.69% in 2024.
  • Over the past 5 years, Angiodynamics' Goodwill & Intangibles (Quarter) stood at $366.7 million in 2021, then fell by 6.55% to $342.7 million in 2022, then decreased by 23.22% to $263.1 million in 2023, then plummeted by 72.21% to $73.1 million in 2024, then decreased by 8.72% to $66.7 million in 2025.
  • Its Goodwill & Intangibles stands at $66.7 million for Q4 2025, versus $68.4 million for Q3 2025 and $69.1 million for Q2 2025.